Quintiles Transnational Holdings Inc (Q) : A.r.t. Advisors scooped up 56,124 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 102,887 shares of Quintiles Transnational Holdings Inc which is valued at $7,860,567.Quintiles Transnational Holdings Inc makes up approximately 0.37% of A.r.t. Advisors’s portfolio.
Other Hedge Funds, Including , Northcoast Asset Management added Q to its portfolio by purchasing 13,195 company shares during the most recent quarter which is valued at $1,008,098. Quintiles Transnational Holdings Inc makes up approx 0.08% of Northcoast Asset Management’s portfolio.Tiaa Cref Investment Management reduced its stake in Q by selling 35,359 shares or 7.88% in the most recent quarter. The Hedge Fund company now holds 413,468 shares of Q which is valued at $31,588,955. Quintiles Transnational Holdings Inc makes up approx 0.02% of Tiaa Cref Investment Management’s portfolio. Lebenthal Asset Management added Q to its portfolio by purchasing 33,135 company shares during the most recent quarter which is valued at $2,531,514. Quintiles Transnational Holdings Inc makes up approx 0.32% of Lebenthal Asset Management’s portfolio.State Board Of Administration Of Florida Retirement System boosted its stake in Q in the latest quarter, The investment management firm added 16,522 additional shares and now holds a total of 107,489 shares of Quintiles Transnational Holdings Inc which is valued at $8,360,494. Quintiles Transnational Holdings Inc makes up approx 0.03% of State Board Of Administration Of Florida Retirement System’s portfolio.Plante Moran Financial Advisors reduced its stake in Q by selling 502 shares or 61.9% in the most recent quarter. The Hedge Fund company now holds 309 shares of Q which is valued at $23,805. Quintiles Transnational Holdings Inc makes up approx 0.02% of Plante Moran Financial Advisors’s portfolio.
Quintiles Transnational Holdings Inc opened for trading at $77.46 and hit $77.54 on the upside on Thursday, eventually ending the session at $77.42, with a gain of 0.16% or 0.12 points. The heightened volatility saw the trading volume jump to 7,20,025 shares. Company has a market cap of $9,173 M.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.90. The company had revenue of $1167.10 million for the quarter, compared to analysts expectations of $1150.61 million. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.78 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Outperform” on Jul 12, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.